MY115721A - Benzothiophene compounds, intermediates, compositionsm, and methods - Google Patents

Benzothiophene compounds, intermediates, compositionsm, and methods

Info

Publication number
MY115721A
MY115721A MYPI96000722A MYPI9600722A MY115721A MY 115721 A MY115721 A MY 115721A MY PI96000722 A MYPI96000722 A MY PI96000722A MY PI9600722 A MYPI9600722 A MY PI9600722A MY 115721 A MY115721 A MY 115721A
Authority
MY
Malaysia
Prior art keywords
alkyl
compositionsm
intermediates
methods
compounds
Prior art date
Application number
MYPI96000722A
Inventor
Alan David Palkowitz
Kenneth Jeff Thrasher
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/396,401 external-priority patent/US5510357A/en
Priority claimed from US08/552,679 external-priority patent/US5856339A/en
Priority claimed from US08/552,564 external-priority patent/US5998441A/en
Priority claimed from US08/554,223 external-priority patent/US5856340A/en
Priority claimed from US08/552,565 external-priority patent/US5977093A/en
Priority claimed from US08/552,890 external-priority patent/US5919800A/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of MY115721A publication Critical patent/MY115721A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/64—Oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

THE PRESENT INVENTION PROVIDES PHARMACEUTICALLY ACTIVE COMPOUNDS OF FORMULA I WHEREIN RL IS -H, -OH, -O(CL-C4 ALKYL), -OCOC6H5, -OCO(CL-C6 ALKYL), OR -OSO2(C2-C6 ALKYL); R2 IS -H, -OH, -O(CL-C4 ALKYL), -OCOC6H5, -OCO(CL-C6 ALKYL), -OSO2(C2-C6 ALKYL), OR HALO; R3 IS 1-PIPERIDINYL, 1-PYR~OLIDINYL, METHYL-1- PYRROLIDINYL, DIMETHYL-1-PYRROLIDINYL, 4-MORPHOLINO, DIMETHYLAMINO, DIETHYLAMINO, DIISOPROPYLAMINO, OR 1- HEX AM ETHYLENE IMINO; N IS 2 OR 3; AND Z IS -O- OR -S-; OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF.FURTHER PROVIDED ARE PHARMACEUTICAL COMPOSITIONS OF COMPOUNDS OF FORMULA I.
MYPI96000722A 1995-02-28 1996-02-28 Benzothiophene compounds, intermediates, compositionsm, and methods MY115721A (en)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US08/396,401 US5510357A (en) 1995-02-28 1995-02-28 Benzothiophene compounds as anti-estrogenic agents
US55276095A 1995-11-03 1995-11-03
US08/552,679 US5856339A (en) 1995-02-28 1995-11-03 Benzothiophene compounds, intermediates, compositions, and methods
US08/552,564 US5998441A (en) 1995-02-28 1995-11-03 Benzothiophene compounds, intermediates, compositions, and methods
US08/554,223 US5856340A (en) 1995-02-28 1995-11-03 Method of treating estrogen dependent cancers
US08/552,565 US5977093A (en) 1995-02-28 1995-11-03 Benzothiophene compounds, intermediates, compositions, and methods
US08/552,636 US5723474A (en) 1995-02-28 1995-11-03 Benzothiophene compounds, intermediates, compositions, and methods
US08/552,890 US5919800A (en) 1995-02-28 1995-11-03 Benzothiophene compounds, intermediates, compositions, and methods

Publications (1)

Publication Number Publication Date
MY115721A true MY115721A (en) 2003-08-30

Family

ID=27569747

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI96000722A MY115721A (en) 1995-02-28 1996-02-28 Benzothiophene compounds, intermediates, compositionsm, and methods

Country Status (4)

Country Link
KR (1) KR100446895B1 (en)
MY (1) MY115721A (en)
NZ (1) NZ286079A (en)
RS (1) RS49886B (en)

Also Published As

Publication number Publication date
KR100446895B1 (en) 2006-04-10
YU11896A (en) 1998-12-23
KR960031454A (en) 1996-09-17
NZ286079A (en) 1997-12-19
RS49886B (en) 2008-08-07

Similar Documents

Publication Publication Date Title
MX9600743A (en) Compounds, intermediates, compositions, and methods.
GEP20084496B (en) Benzothiophene compound, intermediate, composition, and method
YU61595A (en) New naphthyl compounds, intermediates, processes, compositions and methods for the preparation thereof
AR003930A1 (en) PROCEDURE FOR PREPARING COMPOUNDS OF 2-PHENYL-3-PHENOXY OR PHENYLTIO-BENZOTIOFEN AND PHARMACEUTICALLY ACCEPTABLE SALTS, INTERMEDIATE COMPOUNDS OF EXCLUSIVE APPLICATION IN SUCH PROCEDURE AND METHOD FOR PREPARING INTERMEDIATE COMPOUNDS
NZ326132A (en) Retroviral protease inhibiting compounds
AU6724796A (en) Non-steroidal sulfatase inhibitor compounds and their method of use
TW427887B (en) Pharmaceutical composition comprising a benzimidazole derivative for treating viral infections
MX9605156A (en) Peptidylaldehyde derivative and use thereof.
AU7517400A (en) N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent
GB9211172D0 (en) Compounds
CA2149496A1 (en) 11,21-bisphenyl-19-norpregnane derivatives
MX9800718A (en) 2-(4-substituted)-benzylamino-2-methyl-propanamide derivatives.
UA32427C2 (en) The use of benzothiophene or pharmaceutical acceptable salts or solvate thereof for inhibition of angiogenesis and/or angiogenic diseases
DE69628246D1 (en) Naphthyl and dihydronaphthyl compounds as drugs
TW372969B (en) Pharmaceutical composition for minimizing bone loss
MY115721A (en) Benzothiophene compounds, intermediates, compositionsm, and methods
GR3032492T3 (en) Interleukin-1 inhibitor
CA2170479A1 (en) Benzothiophene compounds, intermediates, compositions, and methods
YU6996A (en) USE OF BENZOTHOPHENE TO OBTAIN MEDICINE
EP0832881A3 (en) Benzofluorene compounds, intermediates, compositions, and methods
MY113757A (en) Methods of inhibiting endometrial cancer
GB2333293B (en) Process for the preparation of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide used as anti cancer compounds
TW349096B (en) Benzothiophene compounds, intermediates, compositions, and methods
MY131931A (en) Methods of inhibiting primary endometrial hyperplasia